- News
News
Welcome to the homepage of AIHTA!
AIHTA is an academic non-profit institute. At our website we wish to present our research and give support for health care decision-making. Here all of our reports are available for free. For further information please contact the AIHTA team.
In the News section you will find our most recent publications: newsletter, project-reports etc. Previous reports you might find via Research areas, Research projects and Repository.
Announcement
Horizon Scanning in Oncology - Fact Sheets
We are pleased to introduce you three new Fact Sheets.
Fact Sheet No. 177 (May 2024)
Sugemalimab (Cejemly®) with platinum-based chemotherapy for the first?line treatment of metastatic non-small-cell lung cancer (NSCLC)
Fact Sheet No. 178 (May 2024)
Osimertinib (Tagrisso®) with pemetrexed and platinum-based chemotherapy for the first-line treatment of advanced non-small cell lung cancer (NSCLC)
Fact Sheet No. 179 (May 2024)
Tislelizumab (Tevimbra®) monotherapy or in combination with chemotherapy for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC)
Newsletter
Note: this content is only available in German.
Inhalt
- Editorial: Neue Methoden aus der Gesundheitsökonomie machen Auswirkungen neuer Leistungen auf gesundheitliche Ungleichheit sichtbar
- Pharmakogenetik: personalisierte Verschreibungen
- Hautkrebsprävention: Leitlinien-Empfehlungen zur Primär- und Sekundärprävention
- Gentests bei familiärer Hypercholesterinämie
- Fernüberwachung bei chronischen körperlichen Erkrankungen
- Termine
- Themen-Vorschau
Announcement
Horizon Scanning in Oncology - Fact Sheets
We are pleased to introduce you six new Fact Sheets.
Fact Sheet No. 171 (April 2024)
Fruquintinib (Fruzaqla®) as monotherapy for the treatment of metastatic colorectal cancer (mCRC)
Fact Sheet No. 172 (April 2024)
Capivasertib (Truqap®) with fulvestrant for the treatment ER-positive, HER2 negative locally advanced or metastatic breast cancer
Fact Sheet No. 173 (April 2024)
Alectinib (Alecensa®) as adjuvant treatment following complete tumour resection for adult patients with ALK positive non-small cell lung cancer (NSCLC)
Fact Sheet No. 174 (April 2024)
Nivolumab (Opdivo®) in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma
Fact Sheet No. 175 (April 2024)
Entrectinib (Rozlytrek®) as monotherapy for the treatment of solid tumours with a NTRK gene fusion
Fact Sheet No. 176 (April 2024)
Amivantamab (Rybrevant®) with carboplatin and pemetrexed for the first line treatment of advanced non-small cell lung cancer (NSCLC) with activating EGFR Exon 20 insertion mutations
Newsletter
Note: this content is only available in German.
Inhalt
- Editorial: AIHTA-Framework erleichtert Identifikation öffentlicher Beiträge zur Entwicklung von Innovationen im Gesundheitswesen
- Biofeedback-Therapie bei Migräne
- Preis- und Kostenentwicklung von Orphan Drugs
- Modelle der primären Gesundheitsversorgung für Obdachlose
- CAR-basierte Immuntherapie mit Fokus auf CAR-NK-Zellen
- Termine
- Themen-Vorschau
Project / Prevention and screening, Psychological & psychiatric interventions
Strategies to reduce weight stigmatisation of people with overweight or obesity in the healthcare sector
Project leaders: Sarah Wolf
Project team: Sarah Wolf, Julia Kern
Duration: Mid-April 2024 until Mid-November 2024
Language: German (with English executive summary)
Publication: HTA Project Report No. 160: https://eprints.aihta.at/1547/
Announcement
Horizon Scanning in Oncology - Fact Sheets
We are pleased to introduce you three new Fact Sheets.
Fact Sheet No. 168 (March 2024)
Irinotecan hydrochloride trihydrate (Onivyde® pegylated liposomal) in combination with oxaliplatin, 5-fluorouracil (5-FU) and leucovorin (LV) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas
Fact Sheet No. 169 (March 2024)
Selpercatinib (Retsevmo®) as monotherapy for the treatment of advanced rearranged during transfection (RET) fusion-positive solid tumours
Fact Sheet No. 170 (March 2024)
Enzalutamide (Xtandi®) as monotherapy or in combination with androgen deprivation therapy (ADT) for the treatment of high risk biochemical recurrent (BCR) non-metastatic hormone sensitive prostate cancer (nmHSPC)
Newsletter
Note: this content is only available in German.
Inhalt
- Editorial: „Unmet Need“ (ungedeckte Bedarfe): Eine Definition steht noch aus
- Wundversorgung: Integrierte digitale Wundpflegesysteme
- Implantierte Sensoren: Messung und Monitoring des pulmonal-arteriellen Drucks bei Herzinsuffizienz
- Finanzielle Anreize in der integrierten Versorgung
- Künstliche Intelligenz: Erkennung und Charakterisierung von Darmkrebsvorstufen bei der Darmspiegelung
- Termine
- Themen-Vorschau
Announcement
Horizon Scanning in Oncology - Fact Sheets
We are pleased to introduce you four new Fact Sheets.
Fact Sheet No. 164 (February 2024)
Tislelizumab (Tizveni®) in monotherapy or in combination with chemotherapy for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC)
Fact Sheet No. 165 (February 2024)
Retifanlimab (Zynyz®) as monotherapy for the first line treatment of patients with metastatic or recurrent locally advanced Merkel cell carcinoma
Fact Sheet No. 166 (February 2024)
Ciltacabtagene autoleucel (Carvykti®) for the treatment of relapsed and refractory multiple myeloma (MM)
Fact Sheet No. 167 (February 2024)
Pembrolizumab (Keytruda®) as pre- and post-operative treatment of resectable non small cell lung carcinoma (NSCLC)
Newsletter
Note: this content is only available in German.
Inhalt
- Editorial: Zugang zu Medikamenten in Österreich: Warum Geschwindigkeit nicht alles ist
- Autologe Fetttransplantation bei Arthrose
- Telepathologie bei der intraoperativen Schnellschnittuntersuchung
- Liposuktion zur Entfernung subkutaner (großer) Lipome
- Calcitonin-Gene-Related-Peptide (CGRP)-Antagonisten zur Migräneprävention
- Termine
- Themen-Vorschau
Newsletter
Note: this content is only available in German.
Inhalt
- Editorial: Advanced Practice Nursing (APN): Kompetenz, Leadership, Karriere
- Unterstützung rationaler Impfpolitik
- Implementierung der „Krankenhausausnahmegenehmigung“ für ATMPs in sechs ausgewählten EU-Ländern
- Telemedizin und Künstliche Intelligenz im intramuralen Bereich Österreichs
- Cranberries (Vaccinium macrocarpon) zur Prävention von Harnwegsinfekten
- Termine
- Themen-Vorschau
